UK’s Milner Therapeutics Institute has launched the first functional genomics screening laboratory (FGSL) in collaboration with AstraZeneca, the University of Cambridge and the Medical Research Council. The lab, located in Cambridge, will offer arrayed CRISPR screening to explore the link between genes and diseases, and to identify potential targets for drug discovery across chronic conditions, such as cardiovascular and metabolic diseases. The first projects at the FGSL will study liver regeneration and inflammatory bowel disease.

Have I Been Pwned owner Troy Hunt’s mailing list compromised in phishing attack
Troy Hunt, creator of Have I Been Pwned, was targeted in a phishing attack that compromised his email subscriber list. This incident highlights the risk